Morgan Stanley 13D and 13G filings for Syndax Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-05-07 11:25 am Sale |
2025-03-31 | 13G | Syndax Pharmaceuticals, Inc. SNDX |
MORGAN STANLEY MS |
2,040,013 2.400% |
-3,322,156 (-61.96%) |
Filing |
| 2025-02-05 10:03 am Purchase |
2024-12-31 | 13G | Syndax Pharmaceuticals, Inc. SNDX |
MORGAN STANLEY MS |
5,362,169 6.300% |
5,362,169 (New Position) |
Filing |